Search

everythinglearnresearchcommunity

for

Search:↓

Betulinic acid can help treat hepatitis C by stopping virus replication.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

Axitinib treatment turned a man's grey hair back to black.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Activating CB1 can reduce keratin levels, potentially helping manage psoriasis and aid wound healing.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Ruxolitinib cream may help treat severe hair loss in children.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Abrocitinib may effectively treat stubborn alopecia universalis.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.